Top news of the week: 25.03.2021.
Healthcare
SEC charges co-founders of shuttered microbiome startup uBiome with $60 million fraud
The SEC alleged uBiome's co-founders touted the its work "while hiding the fact that the company's purported success depended on deceit."
The Covid-19 Issue Too Many Are Ready to Overlook, and the Investing Opportunity It Creates Contributed Opinion
Have we forgotten about good Covid 19 Therapeutics? KSS MD PhD, editor-in-chief of PubBio.co, discusses three gems investors should know about.
EpimAb Biotherapeutics Raises $120M in Series C Financing to Advance Bispecific Programs and Broaden Clinical Pipeline
EpimAb Biotherapeutics announces the closing of a $120 million Series C financing round co-led by CMBI and Mirae.
Oramed Forms Joint Venture Company to Develop Oral COVID-19 Vaccines
Jerusalem’s clinical-stage pharmaceutical company Oramed Pharmaceuticals is forming a joint venture with Premas Biotech to develop novel oral COVID-19 vaccine candidates.
STAT expands science and events team
BOSTON — STAT, the nation’s leading health, science and medicine publication, today announced the expansion of its reporting and events teams. After a months long search and the screening ...
What is Trilogy Medical Writing?
Constantly looking for highly motivated people to join their Medical Writing team in Frankfurt am Main, Germany or Downham Market, UK
UPCOMING WEBINAR Case Study: Transgene Mapping Analysis using TLA as Applied to Characterization of hACE2 Strains
This webinar will present a real-world case study in the application of transgene mapping analysis via TLA to hACE2 mouse lines used for coronavirus research.
Pivotal Phase III study shows Roche’s Tecentriq helped people with early lung cancer live longer without their disease returning
First Phase III study to show that a cancer immunotherapy improves disease-free survival in people with resectable early stage lung cancer compared to best supportive care …